QA: GRI Bio Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001824293_2026_GRI_Bio_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001824293, GRI Bio Inc

  xvar xval
0 AssetsCurrent 8,592,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,000
3 remainder_Assets 71,000
4 LiabilitiesCurrent 2,643,000
5 LiabilitiesNoncurrent 15,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,149,521
9 ResearchAndDevelopmentExpense 5,673,821
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 23,497
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 8,666,000
1 Liabilities 2,658,000
2 Expenses 10,823,342
3 Revenues 0
4 StockholdersEquity 6,008,000
5 NetIncome -10,799,845
6 ComprehensiveNetIncome -10,799,845
7 BaseVar 11,085,420
8 EconomicCapitalRatiobeforeLimitedLiability 0.406
9 EconomicCapitalRatio 1.80

Edgar->Model Mapping

Feature Distribution

Change over Time